Загрузка...
Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas
COL-3 is a chemically modified tetracycline that targets multiple aspects of matrix metalloproteinase regulation. This phase I clinical trial was conducted to determine the maximum tolerated dose (MTD) of COL-3 in adults with recurrent high-grade glioma, to describe the effects of enzyme-inducing an...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3197967/ https://ncbi.nlm.nih.gov/pubmed/21547395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-011-0602-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|